|Articles|November 1, 2003
- Pharmaceutical Technology-11-01-2003
- Volume 2003 Supplement
- Issue 5
21 CFR Part 11: Where Are We Now?
Author(s)William Goebel
FDA's revised guidance on 21 CFR Part 11 offers relief to the regulated industry by providing for enforcement discretion and suggesting a risk-based approach to compliance.
Advertisement
Articles in this issue
almost 23 years ago
Improving the Management of Batch Recordsalmost 23 years ago
Understanding Data, Symbol, and Technology Optionsalmost 23 years ago
Web Services in Pharmaceutical Manufacturingalmost 23 years ago
Integrated Compliance ManagementAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
From Warehouse to Lakehouse: A Life Sciences Playbook for Regulated, AI-Ready Data Modernization
2
PharmTech Weekly Roundup—August 7, 2026
3
What Does Moderna's mRNA Flu Vaccine Approval Signal?
4
The FDA Gives Accelerated Approval to Melanoma Treatment
5